Status:

RECRUITING

Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient

Lead Sponsor:

Sheba Medical Center

Conditions:

Severe Mental Disorder

Schizophrenia

Eligibility:

All Genders

18+ years

Brief Summary

This study presents the development and validation of a unique Digital Experience Sampling Method (ESM) questionnaire specifically adapted for monitoring changes in the mental state of patients during...

Detailed Description

The research will be carried out in two phases: 1\. Development of the monitoring questionnaire - Content validity phase - This phase has been fully completed, and its results will be presented in th...

Eligibility Criteria

Inclusion

  • Focus group no.1 :
  • Inclustion Criteria-
  • Hospitalized by consent in the psychiatric wards at the Sheba Medical Center.
  • Signed informed consent to participate in the study. Exclusion Criteria-
  • Patients with a low level of compliance to treatment.
  • Patients suffering from a significant active physical illness, intellectual disability, or complex organic conditions including dementia conditions
  • Patients who cannot read and write in the Hebrew language
  • Patients who are not qualified to give informed consent.
  • Focus group no.2:
  • Staff members work in the inpatient wards and have a valid Israeli license.
  • Signed informed consent to participate in the study.
  • No Exclusion Criteria.
  • Focus group no.3-
  • Inclustion Criteria:
  • Hospitalized by consent in the psychiatric wards at the Sheba Medical Center.
  • Signed informed consent to participate in the study.

Exclusion

  • Patients with a low level of compliance to treatment.
  • Patients suffering from a significant active physical illness, intellectual disability, or complex organic conditions including dementia conditions
  • Patients who cannot read and write in the Hebrew language
  • Patients who are not qualified to give informed consent.
  • Monitoring model- The investigators will recruit 100 subjects hospitalized in the inpatient wards.
  • Inclusion criteria:
  • Adults are consenting hospitalized in a psychiatric hospital at the Sheba Medical Center.
  • Staying in the open part of the ward.
  • Owns a mobile smartphone.
  • Exclusion criteria:
  • Patients with a low level of treatment compliance.
  • Patients with a developmental or intellectual disability, complex organic conditions including dementia.
  • Patients who cannot read and write in the Hebrew language
  • Patients who are incapable of informed consent.
  • The study inclusion criteria for the multi-disciplinary team:
  • Multi-disciplinary team members who work in the psychiatric inpatient wards at the Sheba Medical Center.
  • The staff members will have a valid Israeli license (from the professions of medicine, nursing, psychology, social work, and occupational therapy).

Key Trial Info

Start Date :

May 18 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 18 2024

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT06182787

Start Date

May 18 2022

End Date

October 18 2024

Last Update

June 25 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chaim Sheba Medical Center

Ramat Gan, Israel